Shilpa Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
759.60
19.55 (2.64%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 68.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Corona Remedies
Shilpa Medicare
Marksans Pharma
Alivus Life
Viyash Scientifi
Concord Biotech
Blue Jet Health
Alembic Pharma
Natco Pharma
Jubilant Pharmo
Cohance Life

Why is Shilpa Medicare Ltd ?

1
Healthy long term growth as Operating profit has grown by an annual rate 31.89%
2
With a growth in Operating Profit of 14.85%, the company declared Outstanding results in Jun 26
  • The company has declared positive results for the last 12 consecutive quarters
  • ROCE(HY) Highest at 10.52%
  • NET SALES(Q) Highest at Rs 465.78 cr
  • OPERATING PROFIT TO INTEREST(Q) Highest at 11.26 times
3
Majority shareholders : Non Institution
4
Consistent Returns over the last 3 years
  • Along with generating 85.31% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Shilpa Medicare should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shilpa Medicare for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shilpa Medicare
85.31%
2.14
39.83%
Sensex
-2.63%
-0.19
13.57%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.95%
EBIT Growth (5y)
31.89%
EBIT to Interest (avg)
2.94
Debt to EBITDA (avg)
3.81
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.43
Tax Ratio
13.51%
Dividend Payout Ratio
12.49%
Pledged Shares
8.73%
Institutional Holding
19.44%
ROCE (avg)
5.01%
ROE (avg)
3.58%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
52
Industry P/E
37
Price to Book Value
5.73
EV to EBIT
43.81
EV to EBITDA
32.29
EV to Capital Employed
4.83
EV to Sales
9.19
PEG Ratio
0.51
Dividend Yield
0.07%
ROCE (Latest)
9.82%
ROE (Latest)
8.89%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

30What is working for the Company
ROCE(HY)

Highest at 10.52%

NET SALES(Q)

Highest at Rs 465.78 cr

OPERATING PROFIT TO INTEREST(Q)

Highest at 11.26 times

PBDIT(Q)

Highest at Rs 136.27 cr.

PBT LESS OI(Q)

Highest at Rs 94.93 cr.

PAT(Q)

Highest at Rs 100.88 cr.

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Shilpa Medicare

Net Sales - Quarterly
Highest at Rs 465.78 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 11.26 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Profit (PBDIT) - Quarterly
Highest at Rs 136.27 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 94.93 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 100.88 cr has Grown at 75.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 57.59 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 465.78 cr has Grown at 21.1% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 384.68 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 94.93 cr has Grown at 39.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 68.27 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 100.88 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)